Login / Signup

Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.

Jesse VeenstraJie WangKathleen McKinnon-MaksimowiczTingting LiuBobby ZunigaIltefat HamzaviLi ZhouQing-Sheng Mi
Published in: Annals of the rheumatic diseases (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • oxidative stress
  • binding protein
  • stem cells
  • replacement therapy